Laurus Labs Ltd.
Laurus Labs Ltd.
- ENG - English
- HIN - हिन्दी
- GUJ - ગુજરાતી
- MAR - मराठी
- BEN - বাংলা
- KAN - ಕನ್ನಡ
- ORI - ଓଡିଆ
- TEL - తెలుగు
- TAM - தமிழ்
- NSE14:24 | 20-02-2020
- BSE14:34 | 20-02-2020
Laurus Labs Ltd. Share Price Updates
Laurus Labs Ltd. Quarterly Results
Laurus Labs Ltd Share Price
Laurus Labs Ltd Risk Return Comparisonwith peersNew
Laurus Labs Ltd Financial Comparisonwith peers
Laurus Labs Ltd Share Holding as on 31-12-2019
|Category||No. of shares||Percentage|
MF Ownership Of Laurus Labs Ltd. Shares
Liquid, Ultra Short Term funds and FMPs are not taken into account.More Schemes
About Laurus Labs Ltd.
Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 4690.87 Crore) operating in Pharmaceuticals sector.
Laurus Labs Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 2074.07 Crore to Sales Value (92.75 % of Total Sales), Contract Service which contributed Rs 84.48 Crore to Sales Value (3.77 % of Total Sales), Export Incentives which contributed Rs 26.54 Crore to Sales Value (1.18 % of Total Sales), Traded Goods which contributed Rs 26.39 Crore to Sales Value (1.18 % of Total Sales), Other Operating Revenue which contributed Rs 22.46 Crore to Sales Value (1.00 % of Total Sales) and Scrap which contributed Rs 2.21 Crore to Sales Value (0.09 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 729.59 Crore, up 2.41 % from last quarter Sales of Rs 712.42 Crore and up 37.80 % from last year same quarter Sales of Rs 529.46 Crore Company has reported net profit after tax of Rs 73.48 Crore in latest quarter.
The company’s top management includes Dr.M Venu Gopala Roa, Mr.Venkata Ravi Kumar Vantaram, Mr.Ramesh Subrahmanian, Mr.Narendra Ostawal, Mr.Chandrakanth Chereddi, Dr.Venkata Lakshmana Rao Chunduru, Dr.Satyanarayana Chava, Dr.Ravindranath Kancherla, Dr.Rajesh Koshy Chandy, Ms.Aruna Rajendra Bhinge. Company has Deloitte Haskins & Sells LLP as its auditors As on 31-12-2019, the company has a total of 106,914,499 shares outstanding.